newly diagnosed stage IV pancreatic adenocarcinoma
Showing 1 - 25 of >10,000
Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)
Not yet recruiting
- Ovarian Cancer
- Carboplatin
- olaparibp, embro
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +11 more
- Acupressure Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 12, 2023
China With Non-Small-Cell Lung Cancer That is Unable to be
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- (no location specified)
May 16, 2023
Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +12 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 30, 2022
Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC
Recruiting
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- +7 more
- Gemcitabine Hydrochloride
- +8 more
-
Philadelphia, Pennsylvania
- +1 more
Dec 20, 2022
Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,
Recruiting
- Advanced Fallopian Tube Carcinoma
- +21 more
- Biopsy
- +2 more
-
Bethesda, Maryland
- +2 more
Jan 25, 2023
Breast Cancer Stage IV Trial in Vienna (Datopotamab deruxtecan)
Recruiting
- Breast Cancer Stage IV
- Datopotamab deruxtecan
-
Vienna, AustriaAKH Universitaetsklinikum Vienna, Department f. Internal medicin
May 19, 2023
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,
Not yet recruiting
- Pancreatic Acinar Cell Carcinoma
- +6 more
- Nab paclitaxel
- +5 more
- (no location specified)
Oct 30, 2023
Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Autologous Mesothelin-specific TCR-T Cells
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 31, 2023
Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable
Recruiting
- Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8
- +2 more
- Best Practice
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial in Chicago
Terminated
- Pancreatic Adenocarcinoma
- +2 more
- Pembrolizumab
- Wild-type Reovirus
-
Chicago, IllinoisNorthwestern University
Sep 6, 2022
Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,
Not yet recruiting
- Follicular Lymphoma Stage II
- +2 more
- BMS-986369
- +2 more
-
Ballarat, Victoria, Australia
- +4 more
Mar 15, 2023
Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7
Active, not recruiting
- Stage III Fallopian Tube Cancer AJCC v7
- +14 more
- Epacadostat
- +2 more
-
Minneapolis, Minnesota
- +1 more
Jan 27, 2023
BRCA-Mutated Ovarian Carcinoma, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston (Chemotherapy, Olaparib, Therapeutic
Recruiting
- BRCA-Mutated Ovarian Carcinoma
- +30 more
- Chemotherapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 27, 2022
Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in
Not yet recruiting
- Advanced Biliary Tract Carcinoma
- +32 more
- Biospecimen Collection
- +6 more
-
Chicago, IllinoisNorthwestern University
Feb 6, 2023
Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic
Active, not recruiting
- Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
- +27 more
- Durvalumab
- Guadecitabine
-
Los Angeles, California
- +2 more
Aug 5, 2022
Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and
Recruiting
- Leptomeningeal Metastasis
- +2 more
- intrathecal nivolumab and intrathecal ipilimumab
-
Geneva, Switzerland
- +2 more
Dec 18, 2022
Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in
Recruiting
- Metastatic Colorectal Adenocarcinoma
- +5 more
- Imiquimod
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Aug 26, 2022
Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,
Not yet recruiting
- Pancreatic Cancer Metastatic
- Colorectal Cancer Metastatic
- Neoantigen Vaccine with Poly-ICLC adjuvant
- Retifanlimab
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Aug 5, 2022
Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)
Not yet recruiting
- Stage III Ovarian Cancer
- +5 more
- Cisplatin
- No treatment
- (no location specified)
Dec 12, 2022
Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- +14 more
- Melphalan
- +5 more
-
Boston, Massachusetts
- +1 more
Dec 6, 2022
Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial
Not yet recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +3 more
- Biopsy
- +8 more
- (no location specified)
Jan 13, 2023
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +85 more
- Patient Monitoring System
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Sep 7, 2022